Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #119
mi
from
Deerfield Beach, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #119
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Gainesville, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Naples, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Naples, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Tampa, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New Orleans, LA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Chapel Hill, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Durham, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Portland, OR
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Providence, RI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Memphis, TN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Houston, TX
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #215
mi
from
Richmond, VA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #215
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Spokane, WA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Berkeley, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #170
mi
from
Carlsbad, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #170
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
San Diego, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Jacksonville, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #7138
mi
from
Honolulu, HI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #7138
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Chicago, IL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #225
mi
from
Fort Wayne, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #225
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #175
mi
from
Fulton, MD
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #175
mi
from
Fulton, MD
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
East Lansing, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
East Lansing, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #164
mi
from
Farmington Hills, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #164
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Grand Rapids, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #177
mi
from
Stratford, NJ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #177
mi
from
Stratford, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New York, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #179
mi
from
Patchogue, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #179
mi
from
Patchogue, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Columbus, OH
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #116
mi
from
Dayton, OH
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #116
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #182
mi
from
Falls Church, VA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #182
mi
from
Falls Church, VA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #203
mi
from
Fredericton,
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #203
mi
from
Fredericton,
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Sparrow Clinical Research Institute
mi
from
Lansing, MI
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Sparrow Clinical Research Institute
mi
from
Lansing, MI
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Providence Health and Service
mi
from
Portland, OR
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Providence Health and Service
mi
from
Portland, OR
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Bradenton Cardiology Center
mi
from
Bradenton, FL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Bradenton Cardiology Center
mi
from
Bradenton, FL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Florida Hospital
mi
from
Orlando, FL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
El Paso Cardiology Associates
mi
from
El Paso, TX
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
El Paso Cardiology Associates
mi
from
El Paso, TX
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Lake Martin Laser and Vein Institute
mi
from
Alexander City, AL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Lake Martin Laser and Vein Institute
mi
from
Alexander City, AL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Chandler Regional Medical Center
mi
from
Chandler, AZ
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Chandler Regional Medical Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Hospital-Phoenix
mi
from
Phoenix, AZ
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital-Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
UCSD Health System
mi
from
San Diego, CA
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
UCSD Health System
mi
from
San Diego, CA
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Colorado Heart & Vascular, P.C.
mi
from
Lakewood, CO
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Colorado Heart & Vascular, P.C.
mi
from
Lakewood, CO
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
MedStar Health Research Institute
mi
from
Washington,
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
MedStar Health Research Institute
mi
from
Washington,
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Research Physicians Network Alliance
mi
from
Boynton Beach, FL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Research Physicians Network Alliance
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials